Cargando…
Real-world risk of brain metastases in stage III non-small cell lung cancer in the era of PET and MRI staging
OBJECTIVE: The 2-year incidence of brain metastases (BrMs) in stage III non-small lung cell cancer (NSCLC) has been estimated to be around 30%. However, recent clinical trials have demonstrated considerably lower BrMs rates in this patient population. In this study, we aimed to review the real-world...
Autores principales: | Alhusaini, Saud, Lanman, Tyler A., Ko, Ryan B., Therkelsen, Kate E., Eyben, Rie Von, Diehn, Maximilian, Soltys, Scott G., Pollom, Erqi L., Chin, Alexander, Vitzthum, Lucas, Wakelee, Heather A., Padda, Sukhmani K., Ramchandran, Kavitha, Loo, Billy W., Neal, Joel W., Nagpal, Seema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080021/ https://www.ncbi.nlm.nih.gov/pubmed/37035171 http://dx.doi.org/10.3389/fonc.2023.1139940 |
Ejemplares similares
-
Rectosigmoid Cancer—Rectal Cancer or Sigmoid Cancer?
por: Hui, Caressa, et al.
Publicado: (2022) -
Management of brain metastases in lung cancer: evolving roles for radiation and systemic treatment in the era of targeted and immune therapies
por: Myall, Nathaniel J, et al.
Publicado: (2021) -
Radiological tumor classification across imaging modality and histology
por: Wu, Jia, et al.
Publicado: (2021) -
Increases in Serial Pretreatment (18)F-FDG PET-CT Metrics Predict Survival in Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiation Therapy
por: Prionas, Nicolas D., et al.
Publicado: (2018) -
Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma
por: Koong, Amanda J., et al.
Publicado: (2017)